A recent Medgadget article reported on a new device aimed at combating the opioid crisis. The RESPMETER wearable biosensor from Altair Medical just achieved a breakthrough device designation from the FDA. The device is a wireless sensor that is worn on a patient’s chest to detect Opioid Induced Respiratory Depression (OIRD), a common deadly side effect associated with the use of opioid drugs. When the RESPMETER detects signs of OIRD, it notifies designated first responders who can intervene by administering naloxone.
Quick Hits: FDA Gives Opioid Overdose Detector Breakthrough Status
The device contains a biosensor that detects fatal side effects of opioid abuse.
Mar 13, 2020
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
